Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, September 24, 2026

Snapshot: Sep 24, 2026 · 5:00 PM 100 stocks analyzed

Up Day

Thu, Sep 24, 2026 Divergent High

Nasdaq surges 3.5% on tech rally while S&P 500 gains 0.87%, yet divergent breadth and extreme dispersion expose sharp Healthcare and mid-cap weakness underneath.

55% The market regime was decidedly divergent with NASDAQ 100 rocketing 3.50% while Russell 2000 sank 1.36%, signaling a pronounced tech-led advance that masked underlying weakness in small caps and value names; VIX ticked up 5.8% despite broad gains, a telltale sign of uneven conviction beneath the surface.
30% Healthcare dominated the losers list at 33% of the 50 worst performers with names like NEOV (−24%), TVRD (−18%), and LONA (−17%) falling sharply, while the sector paradoxically claimed 25% of gainers, reflecting acute internal stock-picking divergence and a rotation between winners and losers within the same sector.
15% Extreme dispersion (50 gainers averaging +29.5%, 50 losers averaging −24.1%) and five debutants surging into the gainers list—including LITS, INEO, and THEOR—alongside persistent 3-day streaks in names like YDES, KFIIR (gainers) and GENVR, DCX, HUBC (losers) underscored a wild, stock-picker's environment where single-name catalysts and technicals dominated macro signals.

Healthcare drove 33% of losers 5 names returned after long absences YDES · 3-day gainers streak KFIIR · 3-day gainers streak LITS — first appearance INEO — first appearance

Market Regime

Thu, Sep 24, 2026 Neutral conf: medium macro · prototype

Neutral −100 … +100 · + tailwind / − headwind

VIX15.7 p28 Drawdown-1.2% Held2d · nascent SinceSep 23

Top drivers: VIX percentile ▲ Small-cap leadership ▼ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Thu, Sep 24, 2026 13

S&P 500

7,704.13

+66.37

+0.87%

Dow Jones

51,349.98

−428.06

-0.83%

NASDAQ Composite

26,939.37

+521.07

+1.97%

NASDAQ 100

30,478.86

+1,031.88

+3.50%

DJ US Total Market

75,959.18

+552.77

+0.73%

Russell 1000

4,187.99

+31.61

+0.76%

S&P MidCap 400

3,637.83

−23.70

-0.65%

Russell 2000

2,835.57

−39.06

-1.36%

Russell 2500

1,215.71

−3.65

-0.30%

Russell 3000

4,362.00

+29.23

+0.67%

Nasdaq Financial-100

7,412.78

−24.64

-0.33%

NIFTY 50

23,063.10

−283.30

-1.21%

VIX

15.67

+0.86

+5.81%

Biggest Gainers

Thu, Sep 24, 2026 50

ATXI

Avenue Therapeutics IncHealthcare

$0.50+$0.25

+100.0%

NASDAQ · Mkt cap $824 K

No news headlines were found in the last 48 hours, so the cause of the 100% gain is unknown. The move likely stems from technical factors, delayed news dissemination, or company-specific developments not yet reflected in the RSS feed.

Avenue Therapeutics is a small-cap biopharmaceutical company, and a 100% single-day jump with zero news in the provided headlines is unusual but not unprecedented for stocks in this category. Several explanations are plausible but unconfirmed by the evidence: first, a material announcement (FDA approval, trial results, partnership, or financing) may have been made but not yet indexed in the Yahoo Finance RSS feed used here; second, technical factors such as short covering or algorithmic buying after an oversold condition could drive the move in a low-volume name; third, an off-exchange announcement or earnings release on the company's own channels may have preceded media pickup. Biotech stocks are particularly volatile and can move sharply on clinical or regulatory catalysts. Without headlines, attributing causation is speculation rather than analysis.

PMAX

Powell Max Limited Class A Ordinary SharesFinancial Services

$1.65+$0.86

+97.9%

NASDAQ · Mkt cap $2.1 M

No news headlines were found in the last 48 hours, so the cause of PMAX's 97.92% jump cannot be determined from available reporting. The move likely reflects technical factors, undisclosed company news, or market rumors.

Despite a nearly doubling of share price, no news articles appear in the Yahoo Finance RSS feed for the past two days. This disconnect between price action and public disclosure is notable. For a micro-cap or thinly traded security like PMAX, such sharp moves without matching headlines can result from several categories of catalyst: delayed SEC filing announcements, after-hours guidance changes, insider transactions becoming public, sector rotation, short covering, or retail social media momentum. Without access to real-time company filings, regulatory updates, or the specific trading volume and float characteristics of this security, identifying the precise driver is not possible from the evidence at hand. The rank as the second-biggest gainer suggests broad market interest, but timing and breadth alone do not reveal cause.

GLND

Greenland Energy CompanyEnergy

$5.33+$2.16

+73.7%

NASDAQ · Mkt cap $62 M

Greenland Energy announced an extension of its Jameson Land Farm-Out Agreement with 80 Mile plc on September 24, likely triggering the 73.72% rally as investors responded positively to the deal extension and continued partnership momentum in rare earth energy assets.

The headline from September 24 morning announces a Deed of Variation and Novation extending the Jameson Land Farm-Out Agreement between Greenland Energy and 80 Mile plc. A farm-out agreement extension signals continued operational and financial commitment from a partner, which typically reassures investors about project viability and reduces execution risk. The second headline from September 22 provides macro context, noting strong growth projections for rare earth elements through 2030 with compound annual growth rates of 8.6%, which likely sets a favorable sentiment backdrop for energy and rare earth plays. The timing of the agreement announcement coinciding with the intraday move on September 24 strongly suggests investor reaction to the deal news rather than to the commentary piece from two days prior.

ROC

ROC Energy Acquisition Corp.

$4.14+$1.71

+70.5%

NASDAQ · Mkt cap $83 M

No news headlines were found in the last 48 hours, so the 70% surge cannot be attributed to a specific announced event; the move likely reflects either delayed market reaction to an older announcement, technical trading, or undisclosed catalysts.

Despite ROC Energy Acquisition Corp. posting a dramatic 70.52% single-day gain to rank as the fourth-biggest gainer on NASDAQ, no news headlines appeared in the last 48 hours to explain the move. This absence of contemporaneous coverage creates genuine uncertainty about the catalyst. Reasonable hypotheses for this type of stock include: (1) a significant announcement or filing released after normal news cycles or on a wire service not captured by the RSS feed, or (2) technical or sentiment-driven trading (short covering, options expiration, retail interest, or sector rotation). ROC is a special purpose acquisition company (SPAC), which makes it sensitive to M&A rumors, deal updates, or shifts in investor appetite for blank-check vehicles. Without access to current filings, press releases, or social media activity, the specific driver remains unknown, though the magnitude suggests something material beyond normal daily volatility.

WYTC

WYTEC INTERNATIONAL INC

$1.25+$0.45

+56.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 56% spike in WYTC appears driven by factors other than announced corporate developments. The move is most likely attributable to technical trading, short covering, or untracked rumors.

WYTC jumped 56% on September 24 with zero news coverage found in the prior 48 hours on Yahoo Finance. This gap between a major price move and absence of public news suggests either a delayed market reaction to an unindexed announcement, short-covering in a thinly traded stock, technical breakout trading, or social media-driven momentum that has not yet made mainstream financial news. Microcap stocks like those trading under $2 are particularly susceptible to outsized moves on low volume, retail interest spikes, or rumor. Without headline coverage, we cannot identify a specific catalyst, only the broad category into which this move falls.

YDES

YD BIO LIMITEDHealthcare

$4.75+$1.54

+48.6%

NASDAQ · Mkt cap $317 M

No news headlines were found in the last 48 hours, so the 48.61% gain cannot be attributed to a documented announcement or event. The jump likely reflects a technical rebound, delayed news flow, or sector sentiment in biotech.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to identify a specific news catalyst for YDES's nearly 49% intraday surge. YD Bio Limited is a biotech company, a sector known for sharp moves driven by clinical trial data, regulatory decisions, partnership announcements, or investor sentiment shifts. Without documented headlines, the move could reflect several plausible but unconfirmed causes: a delayed earnings release or clinical update not yet picked up by major news feeds, a short squeeze if the stock has high short interest, a sector-wide biotech rally, or technical oversold recovery. The timing and magnitude suggest an event-driven move rather than pure drift, but without evidence we cannot specify the trigger.

SOS

SOS LimitedFinancial Services

$0.39+$0.15

+48.6%

NYSE · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 48.61% gain on SOS Limited likely stems from technical trading activity, short covering, or undisclosed corporate developments.

SOS Limited experienced a substantial single-day rally with no corresponding news coverage in the Yahoo Finance RSS feed over the past two days. This decoupling between price action and headline coverage suggests the move was driven by factors outside traditional news channels. SOS is a cryptocurrency mining and blockchain-focused company with a history of high volatility and retail investor interest, making it susceptible to technical rebounds after prior weakness, short squeeze dynamics, or social media-driven trading. Additionally, undisclosed corporate announcements, insider activity, or delayed news propagation are possible but speculative explanations. Without concrete news to anchor the analysis, attribution remains speculative.

INLF

INLIF LIMITEDIndustrials

$2.89+$1.38

+48.3%

NASDAQ · Mkt cap $5.2 M

INLIF reported first-half fiscal 2026 financial results on 2026-09-24, likely driving the 48.25% jump as investors reacted to the earnings announcement and company performance.

The news headline confirms that INLIF LIMITED released its first-half fiscal year 2026 financial results on the same date as the stock's 48.25% surge to $2.89, ranking it the eighth biggest gainer of the day. The headline is truncated and does not provide specific metrics such as earnings per share, revenue figures, margin performance, or forward guidance, so the exact nature of what impressed investors remains unclear from the available text. However, the timing alignment between the announcement and the price jump is strong. The company manufactures injection molding machines, a capital equipment business serving industrial customers. The magnitude of the gain (48.25%) suggests investors may have viewed the results as meaningfully better than prior expectations, though without the full earnings release details, the specific drivers of investor enthusiasm cannot be confirmed from this excerpt alone.

PFSA

Profusa, Inc.Healthcare

$3.03+$0.93

+46.5%

NASDAQ · Mkt cap $3.4 M

Profusa jumped 46.51% on news that its Lumee Oxygen Platform passed ISO 13485 certification review, moving the company closer to CE Mark approval in Europe and potential commercialization.

The headline establishes that Profusa received a positive decision from GMED on ISO 13485 certification, with the formal certification expected in early October. ISO 13485 is a critical quality management standard required for medical devices in regulated markets. This milestone directly advances the Lumee Oxygen Platform toward CE Mark approval, which is necessary for European commercialization. For a small medical device company like Profusa, regulatory progress on a lead product represents a material de-risking event, as it moves the technology from development closer to revenue generation. The stock's rank as the ninth biggest gainer suggests broad market recognition of this regulatory milestone's significance. However, the headlines note that additional European MDR conformity assessment work remains, indicating full CE Mark approval is not yet secured.

STAK

STAK Inc. Ordinary SharesEnergy

$1.44+$0.42

+43.3%

NASDAQ · Mkt cap $29 M

No news headlines were found in the last 48 hours for STAK, so the 43.30% jump lacks a clear documented catalyst. The move is likely driven by technical factors, delayed announcements, or rumors.

The absence of recent news headlines for STAK makes it difficult to pinpoint a specific catalyst for today's 43.30% gain. Given that the stock ranks among the top 10 gainers despite no visible news in the provided feed, several scenarios are plausible. First, a material announcement or earnings release may have occurred but not yet propagated to the Yahoo Finance RSS feed at the time of this snapshot. Second, the move could be technical in nature, such as a short squeeze or algorithmic buying triggered by price action or options expiry. Third, sector-wide momentum or a delayed market reaction to an older announcement could be at play. Fourth, a rumor or social media discussion may have driven retail interest. Without access to intraday timestamps or alternative news sources, it is impossible to definitively determine which mechanism drove the move.

SVRN

OceanPal Inc.Industrials

$41.53+$11.28

+34.0%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 34% gain likely reflects either a delayed market reaction to an earlier announcement, technical positioning, or an untracked catalyst.

OceanPal Inc. (SVRN) experienced a significant 33.98% single-day surge while ranking among the day's top gainers, yet no relevant news appeared in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect suggests several possibilities. First, the catalyst could be a company announcement that has not yet propagated to major news aggregators, or it may be a delayed market reaction to news released more than 48 hours prior. Second, given that OceanPal operates in the shipping and maritime sector, the move could reflect sector-wide developments, commodity price movements, or shipping rate improvements that affect the company's asset valuations or earnings outlook. Third, technical factors such as short covering, options expiration effects, or algorithmic trading could drive intraday moves of this magnitude in lower-volume stocks. Without confirmed headline evidence, any specific explanation remains speculative.

FTHM

Fathom Holdings Inc.Real Estate

$0.52+$0.16

+30.4%

NASDAQ · Mkt cap $25 M

No news headlines were available in the last 48 hours, so the 30% rally cannot be attributed to a disclosed event. The move likely reflects either a technical bounce, sector momentum, or an undisclosed catalyst outside the headline feed.

Fathom Holdings is a real estate technology and mortgage services company, and a 30% single-day gain on a stock trading near $0.52 is material. Without news headlines provided, we cannot point to an earnings announcement, guidance change, partnership, or regulatory action as the cause. This leaves several plausible categories: technical bounce (oversold conditions or covering of short positions), sector-wide momentum in real estate or fintech, an internal announcement not yet captured by Yahoo Finance RSS, or market chatter on social platforms. Low-priced stocks under $1 are often more volatile and susceptible to retail trading and short squeezes, which could amplify a small catalyst into a large percentage move. Without headline evidence, we are speculating on the mechanism.

FOFO

HANG FENG TECHNOLOGY INNOVATION CO LTDIndustrials

$2.41+$0.51

+29.0%

NASDAQ · Mkt cap $19 M

No news headlines are available in the last 48 hours, so the 29% gain cannot be directly attributed to a disclosed catalyst; the move likely reflects technical trading, delayed news circulation, or market rumors.

FOFO rose 28.98% to rank 13th among daily gainers, but Yahoo Finance returned no headlines from the past 48 hours. This absence of reported news makes it impossible to identify a specific fundamental catalyst. Stocks like FOFO, trading on NASDAQ and likely subject to lower volume and analyst coverage, can experience sharp moves from several sources: short covering in thinly traded names, retail social media attention, delayed earnings or filing releases that have not yet propagated to mainstream financial news feeds, unannounced partnership or financing developments, or pure technical momentum. Without access to the company's investor relations channels, SEC filings, or specialized equity research, we cannot determine which driver is operative here. The timing gap between the price move and news arrival is also possible if an announcement occurred after market close on 2026-09-23 or very early on 2026-09-24.

AVX

AVX CorpTechnology

$5.46+$1.19

+29.0%

NYSE · Mkt cap $22 M

No headlines were found in the last 48 hours to explain AVX's 28.95% jump, so the catalyst remains unclear; the move could stem from technical factors, delayed news, or market sentiment shifts specific to the electronics components sector.

The absence of recent news headlines for AVX Corp makes direct attribution impossible. A 29% single-day gain for a mid-cap electronics manufacturer typically correlates with significant corporate events such as earnings surprises, major contract wins, analyst upgrades, short-covering, or sector-wide tailwinds. AVX, as a passive component supplier, can be sensitive to cyclical demand signals, supply chain normalization, or supply shocks that tighten availability and pricing. Without headline confirmation, it is reasonable to hypothesize that the move reflects either (1) delayed disclosure of material news not yet captured in the RSS feed, (2) technical or algorithmic buying following a break of resistance, or (3) momentum in the broader electronics or capacitor markets. The lack of transparency here limits confidence in any single explanation.

IRAB.WT

$0.41+$0.09

+28.1%

MRNO

Murano Global Investments PLCReal Estate

$0.31+$0.07

+27.5%

NASDAQ · Mkt cap $19 M

No news headlines were published in the last 48 hours for MRNO, so the +27.45% gain lacks an identified catalyst. The move may reflect technical trading, delayed news digestion, or small-cap volatility.

The absence of recent news headlines makes it impossible to attribute this substantial single-day gain to a specific corporate event. MRNO is a micro-cap investment company trading at $0.31, which typically exhibits higher volatility and thinner liquidity than large-cap stocks. Possible drivers could include short covering if the stock had been heavily shorted, delayed market reaction to older news not captured in the 48-hour window, technical breakout trading, or retail interest in a penny stock. Small-cap investment vehicles like this occasionally experience outsized daily swings on minimal volume or unconfirmed rumors that don't appear in major news feeds. Without corroborating headlines or structural insight into MRNO's recent business or capital events, the specific cause remains speculative.

SPHL

Springview Holdings Ltd Class A Ordinary SharesConsumer Cyclical

$3.16+$0.68

+27.0%

NASDAQ · Mkt cap $5.8 M

No news headlines were available in the last 48 hours, so the 27% jump cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, delayed news dissemination, or unconfirmed market rumors.

Springview Holdings Class A shares jumped 26.98% to rank among the top 20 gainers on September 24, 2026, yet no news articles appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This disconnect between price action and reported news creates ambiguity. For a micro-cap or low-liquidity stock like SPHL trading at $3.16, gains of this magnitude can be driven by several non-news-related factors: short covering or squeeze dynamics if the stock has significant short interest, technical breakout above a resistance level attracting algorithmic or momentum traders, or a material announcement that has not yet been picked up by major news aggregators. Without access to company filings, insider trading databases, or social media chatter, the specific catalyst remains unconfirmed. The stock's low price and potential low float make it sensitive to both small absolute buying volume and sentiment shifts.

MNTK

Montauk Renewables, Inc.

$2.89+$0.61

+26.8%

EZGO

EZGO Technologies Ltd.Consumer Cyclical

$1.07+$0.22

+26.5%

NASDAQ · Mkt cap $2.6 M

No news headlines were available in the last 48 hours, so the 26.53% gain likely reflects either a delayed market reaction to an earlier event, technical trading momentum, or an untracked announcement or catalyst.

The absence of any recent news headlines in the 48-hour window preceding this 26.53% jump makes it difficult to establish a direct causal link. EZGO Technologies is a small-cap stock trading at $1.07, which typically means lower liquidity and higher susceptibility to technical momentum, short-covering, or outsized reactions to relatively small catalysts. Possible explanations for the move include a delayed market reaction to an older announcement not captured in the recent headlines feed, positive developments announced through non-traditional channels, sector-wide momentum in whatever vertical EZGO operates in, or speculative trading activity. Without access to headlines from earlier periods or real-time trading data, attributing this move to a specific corporate event or news announcement is not possible based solely on the evidence provided.

ZSQR

Z Squared Inc.Technology

$3.73+$0.76

+25.6%

NASDAQ · Mkt cap $218 M

No news headlines were found in the last 48 hours for Z Squared Inc., so the 25.59% gain likely stems from technical trading, a delayed announcement not yet indexed by Yahoo Finance, or market speculation.

The absence of any recent news coverage despite a top-20 daily gain is notable and limits confidence in identifying the cause. A jump of this magnitude in a stock trading at $3.73 could reflect several scenarios. First, technical or momentum-driven trading, particularly if the stock had been oversold or was subject to short covering. Second, a material announcement—earnings, regulatory approval, partnership, or capital raise—may have been released but not yet captured in the headline feed used here. Third, sector-wide positive sentiment or a catalyst affecting similar companies could have lifted the stock. Without access to the company's investor relations channels, recent SEC filings, or social media discussion, pinpointing the exact driver is not possible from the data provided.

RBOT

D8 Holdings Corp.Healthcare

$0.05+$0.01

+25.0%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours, so the 25% gain cannot be attributed to a specific announcement or event reported by Yahoo Finance during this window.

RBOT (D8 Holdings Corp.) traded up 25% to $0.05 on September 24, 2026, yet no recent news headlines are available to explain the move. At such low share prices, stocks in this range are often thinly traded and highly volatile, capable of swinging sharply on minimal volume or sentiment shifts. Possible catalysts for this category of security typically include technical rebounds after oversold conditions, rumors or social media activity not yet reflected in traditional news feeds, delayed corporate announcements not yet picked up by major outlets, short-covering rallies, or penny-stock speculation cycles. Without headline evidence, we cannot distinguish among these possibilities.

PLYX

Polaryx Therapeutics, Inc. Common StockHealthcare

$2.13+$0.40

+23.0%

NASDAQ · Mkt cap $105 M

No news headlines were found in the last 48 hours, so the 23% gain cannot be attributed to a reported corporate announcement or market event disclosed to the public during this period.

Without any recent news in the provided sources, the cause of Polaryx's 22.99% single-day jump remains unclear from public disclosures. For a small-cap biotech or therapeutic company like this, typical catalysts include clinical trial results, FDA decisions, partnership announcements, or earnings surprises. However, none of these appear in the available headlines. The move could reflect delayed coverage of an older announcement, technical trading activity, short covering, sector rotation into small-cap therapeutics, or an undisclosed event not yet picked up by major news feeds. Without additional context on the company's pipeline, recent clinical or regulatory developments, or market conditions, attributing the move to a specific cause would be speculation.

NCPL

Netcapital Inc.Financial Services

$1.26+$0.27

+22.3%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the +22.31% gain cannot be attributed to a specific announced event. The move likely reflects either technical trading, a delayed market reaction, or an untracked announcement.

Netcapital Inc. is a fintech and crowdfunding platform company, and a 22% single-day jump with zero corresponding headlines in the major news feed is notable and difficult to explain with certainty. When a micro-cap or small-cap stock makes a large intraday move without visible news, the most common culprits are technical factors such as short covering or momentum traders responding to a prior day's move, a rumor or social media discussion not yet picked up by mainstream financial media, or a delayed market reaction to an announcement made outside the 48-hour window tracked here. Less commonly, it could reflect insider activity or a pre-market announcement not yet widely indexed. Netcapital's retail-focused positioning and fintech sector exposure also make it susceptible to sentiment-driven retail trading swings. Without access to the company's own press releases, SEC filings, or social platforms on the snapshot date, the specific catalyst remains opaque.

IPEXR

Inflection Point Acquisition Corp. V

$0.67+$0.12

+22.3%

NASDAQ

No news headlines were available in the last 48 hours to explain the 22.29% gain, so the catalyst remains unclear and is likely either technical trading activity, an unannounced development specific to the SPAC, or market-driven speculation.

Inflection Point Acquisition Corp. V is a blank-check company (SPAC) trading at $0.67, and the absence of any recent news headlines makes it impossible to attribute the substantial 22.29% single-day jump to a named corporate catalyst such as a merger announcement, filing, or business update. SPACs in this price range typically move on deal rumors, deadline pressures, shareholder voting outcomes, or merger-related disclosures that may not immediately surface in major news feeds. The gain could reflect anticipation of an announcement, resolution of deal uncertainty, technical or algorithmic trading, or retail interest in the security. Without access to SEC filings, press releases, or social media discussion, identifying the specific trigger is not feasible from the available evidence.

KFIIR

K&F Growth Acquisition Corp. II Rights

$0.11+$0.02

+22.1%

NASDAQ

No headlines were published in the last 48 hours, so the 22% gain cannot be tied to a specific news event. Rights offerings and blank-check vehicles often see volatile micro-cap trading driven by technical or speculative factors.

No recent news headlines are available to explain the price movement. KFIIR is a rights offering associated with a SPAC (K&F Growth Acquisition Corp. II), which is a category of security that typically trades with low volume and high volatility. Rights offerings are often illiquid and can be subject to technical bounces, short covering, or speculative positioning that bears no relation to company fundamentals or announced events. A 22% single-day gain on a rights security with no identified catalyst could reflect a delayed market reaction to an older announcement, algorithmic trading, or simply low-volume micro-cap noise rather than a material development.

NTRB

Nutriband Inc.

$8.97+$1.62

+22.0%

LITS

MEI Pharma, Inc.

$1.45+$0.26

+21.9%

WTTR

Select Energy Services IncEnergy

$19.52+$3.86

+21.4%

NYSE · Mkt cap $2.9 B

Select Water Solutions announced a definitive agreement to acquire Pilot Water Solutions, a strategic M&A move that likely drove investor enthusiasm and the 21.45% stock price jump.

The headline explicitly states that Select Water Solutions (NYSE: WTTR) entered into a definitive agreement to acquire Pilot Water Solutions LLC. This represents a material corporate action—an acquisition—which typically generates positive market reaction when perceived as strategic or accretive. The announcement came on the same day as the 21.45% gain, establishing a direct temporal link. M&A announcements in the water services sector can signal growth prospects, expanded capabilities, or revenue synergies. Without additional detail on deal terms, purchase price, financing structure, or management commentary on accretion, we cannot assess whether the market's enthusiasm is fully justified or if it reflects temporary sentiment. However, the headline provides clear, specific evidence of a named acquisition event that coincides with the stock's top-28 ranking in daily gainers.

TJGC

TJGC Group LimitedCommunication Services

$28.27+$4.90

+21.0%

NASDAQ · Mkt cap $44 M

TJGC announced a $2 million share repurchase program authorized by its Board, which likely drove the 21% gain as investors viewed the buyback as a positive signal of management confidence and shareholder-friendly capital allocation.

The headline confirms that TJGC's Board authorized a share repurchase program worth up to $2 million. Share buybacks are typically well-received by markets because they can reduce share count, potentially increase earnings per share, and signal that management believes the stock is undervalued. For a stock trading near $28, a $2 million repurchase is material but not enormous in absolute terms, so the magnitude of the 21% single-day move suggests the market may have been primed for positive news or this buyback was interpreted as a strong confidence signal relative to the company's size and recent price action. The timing and announcement format indicate this is a straightforward corporate action rather than a surprise acquisition or earnings miss reversal.

ALP

Alpha Compute CorpFinancial Services

$5.63+$0.94

+20.4%

NASDAQ · Mkt cap $4.1 M

No news headlines were found in the last 48 hours, so the 20.43% gain cannot be directly attributed to any announced catalyst. The jump may reflect technical buying, a delayed news announcement, or market sentiment shift in the compute/AI sector.

The absence of recent news in the Yahoo Finance RSS feed is notable given the substantial single-day gain that places ALP in the top 30 gainers. This does not rule out a genuine catalyst, as news may have been published outside the monitored feed, embargoed material may have leaked, or the stock may have reacted to sector-wide sentiment (particularly relevant given Alpha Compute Corp's apparent focus on compute infrastructure). Alternatively, the move could reflect technical factors such as short covering, options-related gamma effects, or renewed institutional interest. Without a specific headline or earnings date to anchor the analysis, the most probable explanations are either a missed news event or intra-sector momentum in compute/AI plays, but these remain inference rather than established fact.

USDEW

StablecoinX Inc. Warrants

$4.00+$0.67

+20.1%

INEO

SAG Holdings Limited

$0.61+$0.10

+19.9%

DNA

Ginkgo Bioworks Holdings, Inc.

$10.27+$1.70

+19.8%

QCLS

Q/C Technologies, Inc.

$1.03+$0.16

+19.3%

IFBD

Infobird Co., LtdTechnology

$1.17+$0.18

+18.7%

NASDAQ · Mkt cap $8.7 M

No news headlines were found in the last 48 hours, so the 18.72% gain cannot be directly attributed to a publicly reported event. The move likely stems from technical trading, delayed news digestion, or undisclosed developments.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for IFBD's strong 18.72% single-day gain. Infobird is a smaller-cap NASDAQ stock, and such stocks can experience significant moves on modest trading volume, technical breakouts, or market sentiment shifts unrelated to fundamental announcements. Possible explanations include a delayed market reaction to older news not captured in the 48-hour window, institutional buying interest, retail speculation, or a technical rebound after a prior decline. Without access to intraday trading data, social media chatter, or proprietary transaction logs, determining whether this move reflects genuine new information or momentum-driven trading is not possible.

CRACR

Crown Reserve Acquisition Corp. I Rights

$0.13+$0.02

+18.3%

NASDAQ

No news headlines were found in the last 48 hours, so the 18.29% gain is unexplained by reported events. The jump is likely driven by typical SPAC rights volatility or technical trading activity.

Crown Reserve Acquisition Corp. I Rights (CRACR) is a SPAC rights instrument, a security class known for high volatility and thin liquidity that can produce sharp daily swings independent of news-driven catalysts. Rights securities attached to blank-check companies are especially prone to speculative trading, short covering, and technical moves because their daily volume is often low and their risk/reward profile attracts tactical traders. Without any news provided in the last 48 hours, the 18.29% jump most likely reflects either a technical bounce after prior weakness, positioning by small holders, or delayed market reaction to developments not yet captured in the news feed. It could also reflect changes in the underlying SPAC's odds of completing a business combination, but no such information is available here.

FBDT

First Breach Inc.

$1.07+$0.16

+17.6%

GCDT

Green Circle Decarbonize Technology LimitedIndustrials

$0.66+$0.09

+16.6%

NYSE · Mkt cap $5.2 M

Green Circle Decarbonize Technology announced a 1-for-6 share consolidation effective October 7, 2026, which likely drove the 16.59% gain as the stock price adjusts ahead of the reverse split.

The company announced a 1-for-6 share consolidation, a reverse split that will reduce the number of outstanding shares and proportionally increase the per-share price. This mechanical restructuring explains the intraday price movement. Before the consolidation takes effect on October 7, the stock trades on an unconsolidated basis, so the $0.66 price reflects pre-split economics. After the consolidation, each existing share will be worth approximately six times the pre-split price in nominal terms, though no economic value is created or destroyed by the restructuring itself. The gain likely reflects technical adjustment as traders position ahead of the official consolidation date and the stock's transition to a higher nominal price level. Reverse splits on penny stocks are often associated with delisting prevention or exchange compliance, though the headline does not explicitly state the rationale.

TWST

Twist Bioscience CorpHealthcare

$184.03+$25.55

+16.1%

NASDAQ · Mkt cap $8.5 B

No news headlines were found in the last 48 hours, so the 16.12% gain likely reflects either a delayed market reaction to an earlier announcement, technical buying pressure, or positive sentiment in the biotech sector that was not captured in the RSS feed.

Twist Bioscience is a synthetic biology company that has historically moved on clinical data announcements, partnership developments, revenue guidance, or sector-wide sentiment shifts in genetic engineering and synthetic biology. The absence of any news in the Yahoo Finance RSS feed for the last 48 hours is notable given the magnitude of the move, suggesting either that the catalyst was announced more than 48 hours ago and is only now being reflected in price action, that the move was driven by technical factors or market sentiment rather than company-specific news, or that relevant news was published through channels not captured by this RSS feed. Biotech stocks can also gap higher on short covering or index rebalancing activity. Without the actual news content, a company-specific driver cannot be confirmed.

THEOR

BOA Acquisition Corp. II

$0.29+$0.04

+16.0%

ABLV

Able View Global Inc. - Class B Ordinary SharesConsumer Cyclical

$1.11+$0.15

+15.6%

NASDAQ · Mkt cap $41 M

No news headlines were found in the last 48 hours, so the 15.63% gain cannot be attributed to a disclosed catalyst; the move likely reflects technical trading, delayed news dissemination, or market rumors about this micro-cap stock.

The absence of recent headlines despite a significant single-day jump is notable for a micro-cap stock trading near $1.11. Able View Global is a relatively small-cap company, and such stocks are often subject to technical momentum, short covering, or retail trading activity that can drive sharp moves without accompanying news flow. The gain of over 15 percent in a day is substantial but not unusual for low-priced equities with limited liquidity. Possible explanations include: (1) a news item that has not yet been indexed by the feed used for this snapshot, or (2) trading activity driven by technical chart patterns, option expiration mechanics, or social media attention rather than fundamental news. Without access to intraday information or alternative news sources, pinpointing the exact cause is not possible from the data provided.

OSRH

Bellevue Life Sciences Acquisition Corp.Healthcare

$0.26+$0.04

+15.6%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 15.56% gain cannot be attributed to a specific reported event. The move is likely driven by technical factors, trading volume shifts, or unindexed news for this low-priced SPAC security.

Bellevue Life Sciences Acquisition Corp. (OSRH) is a blank-check company or SPAC, a security type known for volatile, low-volume trading. The stock trades at $0.26, reflecting minimal liquidity and heightened sensitivity to small order flows or speculative positioning. Without any news headlines to anchor the move, the gain is most plausibly explained by one of two mechanisms: first, a technical or algorithmic bounce off a support level or from short covering in a thinly traded name, and second, an untracked announcement, social media mention, or insider activity not yet reflected in major news feeds. SPACs often experience outsized single-day moves on rumored deal activity or insider chatter that does not yet constitute reportable news, making inference difficult without real-time access to regulatory filings or trading chat.

PAAI

Arena Group Holdings Inc

$1.77+$0.24

+15.4%

GRAL

GRAIL, Inc.Healthcare

$125.05+$16.53

+15.2%

NASDAQ · Mkt cap $3.6 B

GRAIL surged 15.23% after the FDA's Medical Devices Advisory Committee voted to back its Galleri multi-cancer early detection blood test, a key regulatory milestone ahead of potential FDA approval.

The headlines establish a clear and concrete catalyst: on September 23-24, 2026, the FDA's Molecular and Clinical Genetics Devices Panel voted favorably on GRAIL's Galleri test, a blood-based screening tool for multiple cancers. This panel recommendation is a significant regulatory step that typically precedes formal FDA approval decisions. The timing of the stock halt on September 23 followed by the 15% surge on September 24 aligns directly with the announcement and dissemination of this favorable advisory vote. Additionally, headlines reference strong real-world data from the PATHFINDER 2 study published in Nature Medicine, which reinforced confidence in the test's clinical utility. One headline questions whether the stock is now overvalued, suggesting the market had already priced in some optimism, but the magnitude of the one-day move indicates this was nonetheless a material positive surprise or confirmation that drove fresh buying momentum.

KRSA

Korsana Biosciences, Inc.

$37.17+$4.87

+15.1%

SWRD

Stewards, Inc

$2.81+$0.36

+15.1%

BALY

Bally's CorporationConsumer Cyclical

$14.06+$1.84

+15.0%

NYSE · Mkt cap $446 M

A Q1 earnings recap article for Bally's appeared on September 23, but the headline does not specify whether results beat or missed expectations, making it unclear whether positive earnings surprises or sector momentum drove the 15% gain on September 24.

The only recent news is a retrospective article comparing Bally's Q1 earnings performance against other casino operators. The headline does not disclose whether Bally's beat or missed consensus, nor does it mention any specific guidance, operational milestones, or strategic developments. This is a descriptive recap rather than breaking news of a corporate event. For a casino operator stock like Bally's, typical catalysts include earnings beats, improved occupancy or revenue per player metrics, debt reduction announcements, or sector-wide tailwinds in consumer discretionary spending. The 15% single-day move is substantial and suggests either a specific positive earnings surprise released around that time, positive commentary within the article itself, or a technical/momentum-driven move in the broader casino sector that day. Without the article's actual content or other concurrent news, the precise driver remains unclear.

SKYQ

Sky Quarry Inc.Energy

$2.92+$0.38

+15.0%

NASDAQ · Mkt cap $12 M

Sky Quarry announced the restart of Nevada's only crude oil refinery following receipt of an air permit and completion of facility upgrades, a material operational milestone that likely drove the 15% gain as the market priced in renewed production capacity.

The headlines establish that Sky Quarry obtained regulatory approval and completed approximately $300,000 in repairs to bring the Eagle Springs refinery back online. This is a concrete operational catalyst for an energy infrastructure company that had its primary asset offline. The company is now focused on ramping production, suggesting meaningful near-term revenue generation ahead. The third headline about West Coast refinery closures creating fuel supply pressure provides favorable market context, implying strong demand tailwinds for a newly operational refinery. The stock's rank at number 48 biggest gainer and the 15% move are consistent with a market re-rating of a small-cap energy firm that has just moved from shutdown to productive operations.

SECZ

Securitize Corp.Technology

$16.50+$2.15

+15.0%

NYSE · Mkt cap $1.2 B

Securitize soared 14.98% following analyst initiation from Cantor Fitzgerald with an Overweight rating, favorable regulatory developments in tokenized securities, and renewed investor enthusiasm around the tokenization boom narrative.

The headlines establish a clear sequence of bullish catalysts over the past 48 hours. Cantor Fitzgerald initiated coverage on September 21 with an Overweight rating and undisclosed price target, sparking a 12% jump. This was followed by commentary that regulators have opened a path for tokenized stock trading, which directly benefits Securitize's core business model. The September 23 headline citing "rosy growth prospects from securities tokenization" and analysts being "highly bullish" reflects broad sentiment shift. Additionally, Cathie Wood's announcement of a tokenized venture fund launching on September 24 reinforces momentum in the tokenization sector as a whole, likely lifting sentiment toward infrastructure plays like Securitize. The combination of analyst validation, regulatory tailwinds, and sector momentum appears sufficient to explain the move.

CYPH

Cypherpunk Technologies Inc.Financial Services

$4.06+$0.53

+14.9%

NASDAQ · Mkt cap $115 M

No news headlines were published about CYPH in the last 48 hours, so the 14.89% gain likely reflects either a delayed market reaction to an unreported announcement, technical buying, or sector momentum rather than a confirmed catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for CYPH's strong 14.89% single-day gain. Cypherpunk Technologies operates in cryptocurrency and blockchain infrastructure, sectors known for rapid sentiment shifts and technical trading. The move could stem from several possible sources: a company announcement that has not yet been indexed by financial news aggregators, positive sentiment in the broader crypto or tech sector, short covering if the stock has meaningful short interest, or retail attention driven by social media or trading forums. Without confirmed news, any explanation remains speculative. The stock's modest absolute price of $4.06 suggests it may be more prone to retail-driven volatility and percentage swings on lower absolute volume than large-cap names.

Biggest Losers

Thu, Sep 24, 2026 50

BENF

BeneficientFinancial Services

$1.45−$1.42

-49.5%

NASDAQ · Mkt cap $33 M

Beneficient announced negotiations with former CEO Brad Heppner to eliminate approximately $130 million in disputed debt, which likely triggered a sharp sell-off due to dilution fears, governance concerns, or restructuring risks.

On September 23, Beneficient disclosed two related announcements regarding efforts to resolve about $130 million in disputed debt tied to former CEO Brad Heppner and to eliminate HCLP debt while restructuring his equity and contract interests. The 49.5% single-day decline suggests the market views the restructuring unfavorably, possibly interpreting it as a forced compromise that will dilute existing shareholders, impose onerous terms, or signal deeper financial distress. The announcement itself does not provide deal terms, pricing, or timing details, leaving investors uncertain about the actual impact. The fact that this debt is "disputed" and linked to a former CEO adds governance red flags. Without seeing the actual restructuring proposal or market expectations prior to the announcement, we cannot definitively rule out that this was anticipated and pre-priced, but the magnitude of the drop implies the market found the outcome worse than hoped or feared.

DFSCW

DEFSEC Technologies Inc.Industrials

$0.02−$0.01

-47.5%

TRT

Trio-Tech InternationalTechnology

$7.27−$4.17

-36.5%

NYSE · Mkt cap $114 M

Trio-Tech reported strong 72% revenue growth driven by AI and automotive semiconductor demand, yet the stock plummeted 36% anyway, suggesting investors either expected far better results, received disappointing forward guidance, or reacted to operational or margin concerns buried in the full anno…

The headline announces a significant positive result—72% fiscal 2026 revenue growth in a hot sector (AI and automotive semiconductors). This would normally support a stock price, yet TRT fell 36%, ranking as the third-largest loser of the day. The RSS excerpt provided is truncated and does not include guidance, margin commentary, or management commentary that would explain such a severe sell-off despite a headline-grabbing growth number. Possible explanations include: (1) the market had priced in much stronger growth and views 72% as a miss relative to expectations, (2) the earnings release contained negative forward guidance or margin compression warnings not visible in the headline snippet, (3) operational challenges, customer concentration risk, or capital allocation concerns were disclosed in the full earnings materials, or (4) the announcement triggered systematic selling unrelated to fundamentals (such as redemptions or technical breakdown). Without access to the complete earnings release, guidance, and conference call, the cause cannot be pinpointed.

XXII

22nd Century Group IncConsumer Defensive

$1.50−$0.85

-36.2%

NASDAQ · Mkt cap $1.4 M

No news headlines were found in the last 48 hours, so the cause of the 36% drop cannot be determined from available public information; biotech and tobacco-alternative stocks like XXII often fall sharply on delayed earnings, regulatory setbacks, or capital structure events.

The absence of news in the Yahoo Finance RSS feed in the 48 hours preceding this sharp decline is notable. XXII (22nd Century Group) is a development-stage company focused on reduced nicotine cigarettes and cannabinoid products, sectors that are sensitive to regulatory announcements, clinical trial results, and funding developments. A 36% single-day drop of this magnitude in a microcap typically reflects either a major announced event (earnings miss, FDA rejection, dilutive financing, insider selling, or litigation) or delayed market reaction to news released earlier. Without headlines, the most probable categories are a regulatory setback affecting product commercialization timelines, an unannounced capital raise, loss of a key partnership, or a delayed disclosure that the market received through other channels before the RSS feed captured it.

GENVR

Gen Digital Inc. Contingent Value Rights

$1.30−$0.75

-35.7%

NASDAQ

Gen Digital's takeover bid for GoDaddy sent GoDaddy shares up 11%, likely reducing the value of Gen Digital's contingent value rights (GENVR) by signaling substantial cash or stock outlay ahead, damaging near-term shareholder returns.

GENVR represents contingent value rights issued by Gen Digital, entitling holders to potential future payments contingent on specified events or milestones. The Financial Times reported on September 24 that Gen Digital made a preliminary takeover bid for GoDaddy, a large web domain and hosting provider. GoDaddy shares surged 11% on this news. While an acquisition could theoretically create long-term value, a major M&A transaction typically requires substantial capital deployment, debt issuance, or equity dilution, all of which reduce the likelihood or magnitude of contingent payments to rights holders. The market appears to have repriced GENVR lower as investors recognize that Gen Digital's capital will be committed to funding this deal rather than available for returning value through the contingent payment mechanism that GENVR holders depend on.

COPL.WT

Copley Acquisition Corp WT

$0.05−$0.03

-34.4%

DCX

Chijet Motor Company, Inc.Consumer Cyclical

$0.06−$0.03

-33.6%

NASDAQ · Mkt cap $322 M

No news was reported in the last 48 hours, so the 33.57% drop cannot be attributed to a specific company announcement. The decline likely reflects broad selling pressure, technical weakness, or untracked catalysts affecting this micro-cap stock.

The absence of any recent headlines in the provided news feed makes it impossible to pinpoint a specific catalyst for the sharp 33.57% decline. DCX trades at $0.06, indicating a micro-cap or penny-stock status, which typically exhibits higher volatility and is more susceptible to technical selling, thin liquidity events, or rumors not captured in mainstream financial feeds. Potential explanations include profit-taking after a recent rally, short selling pressure, a delayed earnings miss or guidance cut released outside the 48-hour window, or sector-wide weakness in automotive stocks. Without confirmed news, the exact trigger remains unclear, though the magnitude of the drop suggests either a material corporate event or forced liquidations in a thinly-traded security.

SSEAR

Starry Sea Acquisition Corp Rights

$0.10−$0.05

-33.3%

SOBR

SOBR Safe, Inc.Technology

$0.09−$0.04

-31.4%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours to explain SOBR's 31% drop, so the cause remains unclear; the move may reflect technical selling, delayed news, or sector-wide pressure in small-cap or specialty stocks.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for this sharp decline. SOBR (SOBR Safe, Inc.) is a small-cap stock focused on alcohol detection and monitoring technology. Stocks of this size and liquidity profile can experience volatile single-day moves from various sources: technical breakdown below support levels, short covering reversals, delayed earnings or compliance filings, insider trading disclosures, or broader sector rotation out of niche technology plays. Without access to intraday volume data, options activity, or social media discussion, we cannot determine whether this was driven by company-specific fundamentals, market-wide deleveraging, or pure technical factors. It is also possible that news exists but was not captured in the Yahoo Finance RSS feed provided.

RDACR

Rising Dragon Acquisition Corp. Rights

$0.07−$0.03

-30.1%

NASDAQ

No news headlines were found in the last 48 hours, but the 30% drop in a SPAC rights security likely reflects deterioration in the underlying acquisition prospect or loss of investor confidence in the deal's terms or timeline.

Rising Dragon Acquisition Corp. Rights is a SPAC-related security, and rights typically trade on the strength of the underlying merger probability and deal terms. The absence of any news in the past 48 hours does not rule out negative developments announced earlier, a decline in sponsor confidence, shareholder redemption pressure, or broader loss of appetite for SPAC deals. Rights are inherently volatile and leveraged instruments; a 30% single-day drop can reflect either a specific adverse event in deal negotiations, a shareholder vote outcome, or a change in the sponsor's commitment to close. Without explicit headlines, the most likely category of cause is either an unannounced deterioration in deal status, redemption notices, or a shift in SPAC market sentiment that particularly hammers lower-conviction merger targets.

ARTL

Artelo Biosciences IncHealthcare

$5.15−$2.15

-29.5%

NASDAQ · Mkt cap $3.3 M

Artelo Biosciences announced promising nonclinical findings for ART27.13 showing 40% weight loss in combination with semaglutide, yet the stock fell 29.45%, suggesting the market may have viewed the data as already priced in, underwhelming relative to expectations, or concerning in some unspecifi…

The headline reports a positive development: a new provisional patent filing for ART27.13 with obesity-indication data showing meaningful weight loss in preclinical models, both as monotherapy and in combination with a GLP-1 agonist. Under normal conditions this would be bullish for a biotech stock. However, the 29.45% single-day decline suggests either the market had already incorporated these findings into the price, the data disappointed relative to prior guidance or analyst expectations, or there is negative information in the full press release not captured in the RSS excerpt. It is also possible that broader market conditions, sector rotation, or unrelated company developments drove the sell-off independent of this announcement.

HCICR

Hennessy Capital Investment Corp. VIII Share Rights

$0.09−$0.03

-28.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 28.63% drop cannot be tied to a specific catalyst. Rights offerings and SPAC-related securities are prone to sharp volatility on low volume and technical factors.

With zero news coverage in the provided sources over the past two days, the driver of this move remains unknown from a headline perspective. HCICR is a share rights offering tied to a SPAC vehicle, which are typically illiquid, low-float securities vulnerable to outsized percentage swings on modest share volumes. The drop could reflect several common patterns: technical selling or rebalancing, a delayed announcement that has not yet appeared in major feeds, redemption activity or liquidation pressure on the parent SPAC, or movements in the underlying warrant or equity tied to the SPAC's timeline and deal status. Without news confirmation or access to intraday order flow, attribution remains speculative.

HUBC

Hub Cyber Security Ltd. - Ordinary SharesTechnology

$2.30−$0.91

-28.3%

NASDAQ · Mkt cap $23 M

No news headlines were found in the last 48 hours, so the 28.35% drop cannot be attributed to a specific announced event. The decline likely reflects either a delayed market reaction to an earlier development, technical selling pressure, or an undisclosed catalyst.

The complete absence of recent news coverage for a stock experiencing a top-13 daily decline presents a data gap. For a cybersecurity firm trading on NASDAQ, price moves of this magnitude typically correlate with earnings misses, revenue guidance cuts, major customer losses, security breaches at the company itself, analyst downgrades, or broader sector rotation. Without headline corroboration, the move could reflect several scenarios: a material announcement may have been delayed in reaching the financial news aggregator, retail or institutional selling may have been triggered by technical resistance breakage or momentum factors, or a market event outside the scope of single-stock news (such as sector weakness in cybersecurity stocks or broader tech selloff) drove the move. The absence of news does not rule out these drivers, only that they are not documented in the provided sources.

GETY

Getty Images Holdings, Inc.Communication Services

$0.16−$0.06

-26.1%

NYSE · Mkt cap $111 M

Getty Images fell 26.14% with no news reported in the last 48 hours, making the specific catalyst unclear; the decline may reflect broad market pressure, technical selling, or undisclosed company developments.

No headlines or news items appeared in the Yahoo Finance RSS feed in the 48 hours preceding this sharp 26 percent drop, which significantly limits our ability to pinpoint a catalyst. Getty Images is a publicly traded content and digital asset platform, and stocks of this type can be sensitive to several factors: shifts in advertising spend or content licensing demand, changes in competitive positioning within digital media, broader weakness in creative services sectors, or technical selling triggered by price action itself. The magnitude of the one-day decline suggests either a material event occurred but was not yet captured in the news feeds sampled here, or market participants reacted to sentiment or data not reflected in mainstream headlines. Without corroborating information, we cannot distinguish between these possibilities.

GCTK

GlucoTrack, Inc.Healthcare

$2.58−$0.93

-25.4%

NASDAQ · Mkt cap $3.7 M

Glucotrack announced a $3 million public offering on September 24, which typically causes immediate shareholder dilution and stock sell-offs; the 25% drop reflects the market's negative reaction to equity issuance.

The headline from September 24 at 12:45 UTC announces the pricing of a $3 million public offering by Glucotrack. Public offerings of equity capital create immediate dilution to existing shareholders, which historically tends to trigger sell-offs especially in smaller-cap biotech stocks where the percentage dilution is material relative to market cap. The company also announced positive news on September 23 regarding its ai² platform and LT-100 clinical progress through CEO Erik Emerson's strategic update, but this positive narrative appears to have been overwhelmed by the dilutive equity raise announced the following day. The timing and magnitude of the 25% decline aligns with typical market reactions to equity offerings in this sector, where capital raises are often viewed as a sign of cash burn or desperation and trigger technical selling regardless of underlying business developments.

FEED

ENvue Medical, Inc.Healthcare

$0.45−$0.15

-24.8%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 24.82% drop cannot be attributed to a specific disclosed event; the decline may reflect technical selling, delayed market reaction to earlier news, or sector headwinds.

The absence of any Yahoo Finance headlines in the last 48 hours means we cannot identify a named catalyst for FEED's sharp 24.82% decline. ENvue Medical is a small-cap medical device company, and stocks in this category are susceptible to several types of pressure independent of same-day announcements: revenue or profitability concerns, delayed reaction to earnings or guidance released more than 48 hours ago, insider selling or dilutive offerings, clinical trial setbacks or regulatory delays that may not immediately appear in news feeds, analyst downgrades, or broad sector rotation out of small-cap healthcare. The stock's ranking as the 16th biggest loser suggests a material intraday move, yet without corroborating headlines, the precise driver remains opaque. This is especially common for low-priced stocks, where technical factors and low liquidity can amplify moves.

NEOV

NeoVolta, Inc.Industrials

$2.39−$0.76

-24.1%

NASDAQ · Mkt cap $214 M

NeoVolta reported a massive earnings miss (revenue down 99% YoY for Q4) and posted a significant quarterly loss, triggering the 24% stock collapse despite positive commentary about Georgia facility ramp and future orders.

The headlines establish that NeoVolta released Q4 2026 earnings results on September 23-24, with catastrophic misses: revenue fell 99.03% below estimates and earnings surprised negatively by 140%. While management commentary mentions 58% fiscal-year growth and optimistic statements about production ramp-up, SK ON collaboration, and expected orders by year-end, these forward-looking remarks were insufficient to offset the stark quarterly revenue collapse. The magnitude of the earnings miss—essentially near-zero revenue in Q4 versus analyst expectations—likely indicates a severe operational disruption or major delays in commercialization that surprised the market. Despite the positive tone around future capacity and orders, investors appear to have interpreted the current-quarter numbers as evidence that the strategic pivot and manufacturing expansion have not yet translated into material revenue generation, creating a credibility gap between management guidance and actual execution.

TWG

Top Wealth Group Holding Limited Ordinary SharesConsumer Defensive

$0.21−$0.06

-23.8%

NASDAQ · Mkt cap $22 M

Top Wealth Group announced a positive profit alert on September 23rd, yet the stock fell 23.8% the next day, suggesting the market either viewed the alert as insufficient, priced in worse news, or reacted to undisclosed details in the full announcement not captured in the headline.

The company issued what it labeled a positive profit alert on September 23rd, but this announcement coincided with or preceded a sharp 23.8% decline by September 24th. This counterintuitive move—a stock falling after positive news—occurs when markets either find the numbers disappointing relative to expectations, detect warning language buried in the release, or when the alert masks deteriorating forward guidance. The headline provided is truncated and does not include the actual profit figures, margin changes, or forward-looking statements that would explain why positive earnings surprised the market negatively. Without the full text of the alert or context on analyst expectations, it is impossible to determine whether the decline reflects a lower-than-expected beat, margin compression, guidance cuts, or an entirely different catalyst. The timing suggests the announcement itself was the trigger, but the direction is anomalous and warrants review of the complete release.

SDHIR

Siddhi Acquisition Corp Right

$0.13−$0.03

-23.7%

IPDN

Professional Diversity Network IncIndustrials

$4.20−$1.22

-23.6%

NASDAQ · Mkt cap $2.7 M

No news headlines were found in the last 48 hours, so the 23.64% drop cannot be directly attributed to a specific disclosed event. The decline likely reflects either a delayed market reaction to earlier news, technical selling, or undisclosed negative information.

The absence of recent news headlines makes it impossible to identify a specific catalyst for IPDN's sharp 23.64% decline. Professional Diversity Network is a small-cap company focused on diversity and inclusion networking services, which can experience heightened volatility and be sensitive to broader market sentiment shifts. Without headline evidence, potential explanations could include a delayed market reaction to earnings or guidance released more than 48 hours ago, technical factors such as stop-loss triggers or short covering, or undisclosed news that has not yet appeared in the Yahoo Finance RSS feed. Small-cap stocks in this space sometimes face liquidity challenges that can amplify single-day moves. However, these remain plausible categories rather than established causes.

EONR.WT

EON Resources Inc WT

$0.08−$0.03

-23.1%

JAGX

Jaguar Health IncHealthcare

$6.94−$2.06

-22.9%

NASDAQ · Mkt cap $4.5 M

Jaguar Health collapsed 22.91% today following a severe 59% drop yesterday, likely driven by negative clinical or regulatory news tied to its Crofelemer pediatric MVID program that was touted as a major positive less than 48 hours prior.

The timeline is striking: on September 23 premarket, JAGX surged over 10% after reporting plans to file for approval of Crofelemer powder for pediatric MVID in mid-2027. By later that same day, the stock had collapsed 59%, suggesting a dramatic reversal or clarification of that narrative. Today's 23% additional decline suggests the market is still pricing in negative implications from whatever caused yesterday's rout. The headlines reference the stock getting "crushed" and "beaten down" but provide no specifics about the clinical, regulatory, or financial catalyst. For a micro-cap biotech stock, typical catalysts include failed trial data, FDA communications, manufacturing issues, financing dilution, or insider selling. Without the actual adverse news detail, the cause remains inferred rather than confirmed.

GreenPower Motor Company Inc.

$0.58−$0.16

-22.1%

HCTI

Hybrid Coating Technologies, Inc.Healthcare

$0.71−$0.20

-21.9%

NASDAQ · Mkt cap $14 M

Healthcare Triangle announced a proposed $30 million acquisition of Roboticom's industrial robotics business via LOI on September 23, likely disappointing investors who viewed the move as value-destructive or a strategic distraction from core healthcare operations.

The news headlines establish that HCTI signed a non-binding letter of intent to acquire Roboticom's industrial precision robotics automation business for up to $30 million on September 23. This is a material corporate action that appears to have triggered the 21.9% sell-off on September 24. The market's negative reaction suggests investor skepticism about the deal's strategic fit, capital allocation, or execution risk. A micro-cap healthcare technology company pivoting into industrial robotics represents a significant business shift that may have raised concerns about management distraction, integration challenges, or dilution to existing shareholders. The non-binding nature of the LOI means deal terms could still change, adding uncertainty. Without access to the full press release or analyst commentary, the exact nature of shareholder concern cannot be pinpointed, but the timing and magnitude of the drop align squarely with the deal announcement.

SFIX

Stitch Fix Inc

$2.21−$0.62

-21.8%

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.05−$0.01

-21.2%

NASDAQ · Mkt cap $5.5 M

Hepion Pharmaceuticals fell 21.21% on September 24, 2026, with no news headlines in the last 48 hours to explain the move, suggesting the decline was driven by technical factors, insider selling, or delayed market reaction to older news.

No recent news headlines are available in the 48-hour window preceding this sharp 21% decline. For a micro-cap biotech stock trading at $0.05 per share, typical drivers of sudden drops include negative clinical trial results or regulatory setbacks that may have been announced more than 48 hours ago, sudden insider selling or secondary offerings, short-covering reversals, or technical capitulation in a stock already at penny-stock levels. Without fresh headlines, the move cannot be attributed to a specific announced event. The lack of coverage itself is notable and consistent with a low-liquidity, speculative security where negative sentiment can accumulate and crystallize rapidly with minimal news trigger.

AGRZ

Agroz Inc.Consumer Defensive

$0.21−$0.05

-21.2%

NASDAQ · Mkt cap $6.9 M

Agroz announced a reverse stock split, which typically signals financial distress or a push to regain compliance with exchange listing standards. This news likely triggered the 21% intraday selloff as investors feared dilution or underlying business deterioration.

The headline confirms that Agroz announced an anticipated reverse stock split on the same day as the sharp decline. Reverse splits are commonly interpreted by markets as a negative signal, often associated with companies attempting to meet minimum share price requirements, reduce share count to improve optics, or address liquidity stress. The stock is trading at $0.21, well below typical exchange minimum thresholds, making such an action predictable but bearish. The headline is truncated and does not specify the split ratio, timing, or explicit reason, so the precise mechanics remain unclear. However, the market's reaction aligns with historical patterns: announcement of a reverse split frequently triggers selling pressure from retail investors and those concerned about financial stability, regardless of the company's underlying operations or near-term catalysts.

LESL

Leslie''s IncConsumer Cyclical

$0.34−$0.08

-20.0%

NASDAQ · Mkt cap $6.1 M

No news headlines appeared in the last 48 hours to explain Leslie's Inc's 20% single-day drop, making the catalyst unclear from available information.

Leslie's Inc experienced a significant 19.95% decline on September 24, 2026, ranking as the 28th biggest loser of the day. However, no relevant news headlines were published in the preceding 48 hours according to the provided Yahoo Finance RSS feed. This absence of news coverage makes it difficult to pinpoint a specific catalyst. Pool and spa retailers like Leslie's are typically sensitive to macroeconomic conditions, consumer discretionary spending, seasonal demand patterns, and competitive pressures. The sharp drop could reflect a delayed market reaction to prior earnings or guidance, technical selling, broader retail sector weakness, short-covering, or an untracked announcement. Without corroborating headlines or structural details about the stock itself, we cannot distinguish between these possibilities on the evidence provided.

BKYI

Bio-key International IncIndustrials

$1.99−$0.49

-19.8%

NASDAQ · Mkt cap $4.3 M

BKYI fell 19.76% despite announcing FIDO Alliance certification for its Passkey:YOU authentication product on September 23, suggesting the market either viewed the news as already priced in, failed to view it as sufficiently material, or reacted to unrelated negative factors.

The headline announces a genuine positive development: BIO-key received full FIDO Alliance certification for Passkey:YOU, a biometric authentication solution targeting the agentic AI market. This is a credible technical achievement that could unlock new revenue channels. However, the stock dropped sharply the next day, which is counterintuitive if the market viewed this as genuinely transformative news. Possible explanations include: (1) the market saw it as incremental progress for a company with a history of modest commercial traction and did not view certification alone as a major revenue catalyst, (2) the company's size and historical trading pattern mean positive announcements often fail to sustain upward momentum, or (3) unrelated selling pressure, sector rotation, or a delayed negative catalyst overshadowed the announcement. Without earnings data, guidance changes, or other context in the 48 hours around the announcement, the move remains difficult to attribute definitively to the news itself.

IPEX

Inflection Point Acquisition Corp.

$7.48−$1.82

-19.6%

NOTE

FiscalNote Holdings, Inc.Technology

$0.03−$0.01

-19.4%

NYSE · Mkt cap $2.0 M

No headlines were found in the last 48 hours for FiscalNote, so the 19.44% drop cannot be directly attributed to announced news. The decline likely reflects either technical selling, broader market weakness, or undisclosed company developments.

The absence of any recent news headlines makes it impossible to tie this significant single-day loss to a specific catalyst. FiscalNote is a government intelligence and legislative analytics software company, and stocks in this category can be sensitive to several factors including quarterly earnings misses, changes in customer concentration or contract values, analyst downgrades, broader tech sector selloffs, or general liquidity events in lower-priced securities. At $0.03 per share, NOTE is also in penny stock territory, where trading can be volatile and thin liquidity amplifies price swings. Without confirmed news, the most honest assessment is that this move lacks an identifiable headline-driven catalyst in the available information.

KPLT

Katapult Holdings, Inc.Technology

$5.76−$1.36

-19.1%

NASDAQ · Mkt cap $29 M

No news headlines were found in the last 48 hours, so the 19.1% single-day decline likely stems from technical selling pressure, a delayed negative announcement, or sector-wide weakness in fintech or consumer lending.

Katapult Holdings operates in the buy-now-pay-later and point-of-sale financing space, a sector that has experienced significant volatility and headwinds since 2022. Without any news catalyst identified in the past two days, the sharp 19% drop could reflect several categories of cause: sector rotation away from high-growth fintech names, deterioration in consumer credit or lending sentiment more broadly, an unreported earnings miss or guidance cut, or potential short covering unwinding. KPLT trades at relatively modest volume compared to mega-cap peers, making it susceptible to technical moves and news that may lag published headlines. A delayed SEC filing, earnings release, or loan-book quality issue could also explain same-day moves even if not yet widely reported.

WETO

Webus International Limited Ordinary SharesTechnology

$1.90−$0.44

-19.0%

MSS

Maison Solutions Inc. - Class A Common StockConsumer Defensive

$1.70−$0.40

-19.0%

NASDAQ · Mkt cap $1.6 M

MSS fell 19% on September 24 with no news identified in the last 48 hours, suggesting the move may reflect delayed earnings release, sector rotation, or technical/liquidity factors rather than a specific announced catalyst.

No headlines were available in the Yahoo Finance RSS feed for the last 48 hours surrounding this 19% single-day drop. This absence of news is significant and suggests the stock move was not driven by a named announcement, earnings beat or miss, regulatory action, or M&A event that would typically generate immediate press coverage. For a micro-cap equity trading at $1.70, possible explanations include delayed or after-hours earnings release not yet indexed in the news feed, short-seller activity or technical breakdown in a low-liquidity security, broader sector pullback unrelated to company-specific news, or market-maker adjustment in a thinly-traded name. Without access to real-time trading logs, SEC filings, or broader market context for that date, it is not possible to pinpoint the driver.

FRGT

Freight Technologies IncTechnology

$0.39−$0.09

-18.9%

NASDAQ · Mkt cap $1.0 M

No news headlines were found in the last 48 hours, so the 18.94% drop cannot be directly attributed to any published announcement. The decline likely reflects technical selling, broader market weakness, or undisclosed company developments.

The absence of recent news in the Yahoo Finance RSS feed means we cannot point to a specific catalyst such as earnings, guidance, partnerships, or regulatory developments. For a micro-cap stock trading at $0.39, price swings of this magnitude are not unusual and can result from several sources: general market conditions or sector rotation, short covering or forced liquidation, technical breakdown below key support levels, or company-specific information not yet syndicated through major news outlets. Small-cap and penny stocks often exhibit volatile intraday moves on low volume, and retail investor behavior can amplify these moves independently of fundamental news. Without additional context about trading volume, short interest, or broader market conditions on September 24, 2026, determining the root cause remains speculative.

AXG

Solowin Holdings

$1.31−$0.30

-18.7%

CLRO

ClearOne IncTechnology

$3.43−$0.79

-18.7%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours to explain CLRO's sharp 18.72% decline, so the cause remains unclear based on available public information.

ClearOne Inc dropped nearly 19% on September 24 with zero news coverage captured in the last 48 hours. This disconnect between price action and headline flow suggests either a delayed market reaction to an older announcement, an intraday rumor or social media catalyst not yet picked up by major news outlets, a technical breakdown triggered by a stock price or volume threshold, or a sector-wide selloff affecting smaller-cap communication equipment companies. Without access to earnings surprises, guidance changes, regulatory actions, or material contract losses, we cannot pinpoint a specific corporate event. For a company in the communications and conferencing space, typical catalysts would include product cycle concerns, competitive pressure, or shifts in enterprise IT spending, but none of these are evidenced in the provided information.

CRMT

America's Car-Mart Inc-TXConsumer Cyclical

$1.37−$0.31

-18.5%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours for CRMT, so the 18.51% drop likely reflects either a delayed market reaction to an earlier event, technical selling, or an earnings release or guidance warning that has not yet appeared in the RSS feed.

With no recent headlines available to explain the sharp decline, we must rely on inference about what typically drives used auto lending and retail automotive finance stocks like America's Car-Mart. Possible catalysts in this category include disappointing quarterly earnings, a reduction in earnings guidance, an increase in loan charge-offs or credit losses, a ratings downgrade from an analyst or rating agency, negative commentary on consumer credit conditions or vehicle demand, or deterioration in used car market dynamics. It is also possible that news has been released but has not yet propagated to the Yahoo Finance RSS feed as of the snapshot date. Without access to the actual earnings report, guidance statement, or other material development, we cannot definitively identify which scenario occurred.

SCTX

Scribe Therapeutics Inc.Healthcare

$21.61−$4.90

-18.5%

NASDAQ · Mkt cap $586 M

No headlines were available in the last 48 hours to explain Scribe Therapeutics' 18.47% drop, making the cause unclear without additional information about company-specific news or market events.

The absence of recent news headlines within the 48-hour window makes it difficult to pinpoint a specific catalyst for SCTX's sharp decline. For a biotech company like Scribe Therapeutics, which specializes in gene-editing therapeutics, typical drivers of large single-day moves include clinical trial results, FDA regulatory decisions, capital raises, partnership announcements, or shifts in broader sector sentiment. The magnitude of the drop (down 39 largest loser) suggests a material event rather than routine volatility. Without headline evidence, the cause could be a late-breaking announcement not yet captured in the RSS feed, broader biotech sector weakness, insider selling patterns, short-term technical selling, or developments disclosed through other channels. Additional research into press releases or SEC filings from the date would be necessary to identify the specific trigger.

NWTG

Sacks Parente Golf, Inc.Consumer Cyclical

$0.96−$0.21

-18.4%

NASDAQ · Mkt cap $6.3 M

Newton Golf announced entry into the U.S. critical minerals sector via a Nevada beryllium-tungsten project option, but investors reacted negatively, likely viewing the pivot away from golf equipment as strategically misguided or dilutive.

The headline announces a material strategic pivot—Newton Golf, marketed as a technology-forward golf equipment company, is now acquiring an option on a critical minerals project. This type of diversification announcement into an unrelated sector (mining/minerals versus golf equipment) often triggers skepticism among investors who question management's focus and capital allocation priorities. The 18.42% single-day drop suggests the market viewed this move unfavorably, possibly due to concerns about dilution of shareholder value, lack of expertise in mining operations, or the perception that this represents a distressed pivot rather than a planned expansion. Alternatively, the announcement itself may have been preceded by trading based on rumors or insider information, with the official news triggering profit-taking or short selling. Without context on the company's financial condition or prior guidance, it is unclear whether this is a bold diversification or a sign of trouble in the core golf business.

TVRD

Tvardi Therapeutics IncHealthcare

$1.07−$0.24

-18.3%

NASDAQ · Mkt cap $25 M

Tvardi stock fell 18.32% despite releasing positive preclinical data on its STAT3 inhibitors for ulcerative colitis, suggesting the market either dismissed the early-stage results or was driven by unrelated factors like profit-taking or sector weakness.

The company released preclinical data showing favorable colon accumulation and STAT3 modulation for its oral small molecule candidate, which is objectively positive news. However, the stock dropped sharply on the same day. This disconnect suggests either that market participants viewed preclinical colitis data as insufficient to justify current valuation, that the news was already priced in, or that selling pressure from unrelated factors (sector rotation, portfolio rebalancing, broader biotech weakness) overwhelmed positive sentiment. For early-stage biotech firms trading near $1, price moves of this magnitude on single data releases are common due to thin liquidity and high speculation sensitivity. Without additional context on volume, short interest, or concurrent sector moves, the precise trigger remains unclear.

DCOY

Decoy Therapeutics IncHealthcare

$3.14−$0.69

-18.0%

SLXN

Biomotion SciencesHealthcare

$0.26−$0.06

-18.0%

NASDAQ · Mkt cap $540 K

No news headlines were available in the last 48 hours to explain the 17.97% drop in SLXN, so the cause remains unclear without additional context or market data.

The absence of news headlines over the past 48 hours makes it difficult to pinpoint a specific catalyst for SLXN's steep 18% decline. Biomocion Sciences as a small-cap biotech stock trading at $0.26 could have experienced this move due to several plausible but unconfirmed categories: an after-hours or pre-market announcement not yet indexed by news feeds, a delayed filing or disclosure that moved the market, technical selling pressure on a heavily shorted or thinly-traded ticker, broader biotech sector weakness, or deterioration in clinical trial data or regulatory status. Early-stage biotech stocks in particular are sensitive to clinical milestones, funding news, and partnership announcements, any of which could have driven this move. However, without specific headlines or verifiable corporate events, this remains inference rather than established fact.

VTGN

VistaGen Therapeutics IncHealthcare

$0.30−$0.06

-17.8%

NASDAQ · Mkt cap $11 M

VistaGen presented positive clinical data for fasedienol in severe social anxiety disorder on September 24, yet the stock fell 17.79%, suggesting the market viewed the results as insufficient or disappointing relative to expectations.

The company released exploratory subgroup analysis data from the Psych Congress 2026 presentation on the same day as the decline. Two separate headlines frame the findings as positive, with one explicitly stating very severe SAD potential. However, the magnitude of the sell-off despite positive news framing suggests investors may have found the data underwhelming, the efficacy margins too narrow, or the path to approval less clear than anticipated. Alternatively, the data could have missed specific efficacy thresholds the market was pricing in, or concerns about the competitive landscape or regulatory pathway may have outweighed the positive messaging. Without access to the actual poster presentation or consensus analyst expectations, the precise reason for disappointment cannot be determined from these headlines alone.

BFRG

Bullfrog AI Holdings, Inc. Common Stock

$0.76−$0.17

-17.8%

AVAT

Avalanche Treasury CorporationFinancial Services

$1.81−$0.39

-17.7%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours to explain AVAT's 17.73% decline, suggesting the drop may be driven by technical selling, broader market conditions, or unreported developments.

The absence of recent news headlines leaves the specific catalyst for this sharp 17.73% single-day drop unclear. Without identifiable fundamental triggers such as earnings misses, guidance revisions, insider selling, or sector-wide headwinds documented in the provided sources, the move appears to be either technical in nature (profit-taking, momentum reversal), driven by market-wide conditions on September 24, 2026, or caused by developments not yet captured in public financial news feeds. Avalanche Treasury Corporation is a micro-cap security with limited analyst coverage, which can result in wider price swings on lower liquidity and delayed information dissemination. The rank as the 46th biggest loser suggests this was a notable decline but not extraordinary in absolute terms across the market that day.

RAVE

Rave Restaurant Group Inc

$2.28−$0.49

-17.7%

MBAI

Check-Cap Ltd.Healthcare

$4.51−$0.96

-17.6%

NASDAQ · Mkt cap $11 M

No news headlines were available in the last 48 hours to explain the 17.55% drop in MBAI stock. The decline likely reflects either delayed reaction to earlier announcements, broader market conditions, or internal developments not yet captured in major news feeds.

Check-Cap Ltd. is a medical device company focused on colorectal cancer screening, and as a small-cap NASDAQ stock it can experience significant daily volatility. With no recent headlines identified in the Yahoo Finance RSS feed within the last 48 hours, the cause of this substantial single-day decline remains unclear from public news sources. For medical device and biotech companies, typical catalysts include clinical trial results, regulatory decisions from the FDA, funding announcements, partnership developments, or changes in analyst ratings. Without access to news from the past 48 hours, we cannot determine whether this drop was driven by company-specific news, sector headwinds affecting medical device stocks, broader market decline, or a delayed market reaction to earlier announcements.

LONA

Leonabio Inc

$4.90−$1.01

-17.0%

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02−$0.00

-16.3%

NASDAQ · Mkt cap $1.1 M

No news headlines were published in the last 48 hours, so the 16.32% decline on September 24 cannot be directly attributed to a specific company announcement or market event disclosed in that window.

The absence of recent news makes it impossible to identify a concrete catalyst for WTER's sharp one-day drop. However, Alkaline Water Co is a microcap stock trading at $0.02, a price range typical of distressed companies facing liquidity or fundamental challenges. Microcaps in this price tier are highly susceptible to technical selling, short positions, reverse split announcements, or delayed disclosure of adverse earnings or regulatory developments that may not yet appear in major news feeds. The lack of headline coverage itself is notable for a stock experiencing the 50th-largest one-day decline on NASDAQ, suggesting either that material information has not yet reached mainstream financial news services, or that the move was driven by technical factors, institutional rebalancing, or broker delisting risks rather than company-specific news.